Over 600 authors from some 52 countries are involved with the preparation of CIDG Cochrane Reviews. The full list of authors is available in the CIDG module document in the Cochrane Library.
The work of the CIDG is supported by editors and administrative staff. The editors provide feedback on reviews and help the editorial team develop policies and guidelines for the Group. They also help define the scope and topics covered by the CIDG. Any editor who is an author is excluded from editorial decisions on the review for which they are contributors.
Physician and epidemiologist based in Makerere University Medical School, Mulago Hospital, Uganda. Dr. Bukirwa works with Uganda Malaria Surveillance Programme (UMSP) to oversee activities at malaria surveillance sites across the country. She works closely with staff of the Malaria Control Programme of the Ugandan Ministry of Health to advise on evidence-based malaria control policy. Dr Bukirwa also spearheads a project to implement pharmacovigilance for antimalarial drugs at the surveillance sites. Dr Bukirwa joined the CIDG in 2002 as an author and has since produced several reviews mainly around interventions in malaria. Read more about her work in this CIDG 'Meet the Editor' article.
Reader in Infection Pharmacology and Honorary Consultant Physician, Institutes of Infection and Global Health and of Translational Medicines, University of Liverpool,UK. Dr Davies is a physician who learned infectious diseases in South Africa, Thailand and the UK. His research work spans the development and evaluation of anti-infective agents from preclinical pharmacology to systematic reviews with a particular emphasis on tuberculosis and HIV. He authored Cochrane reviews on rifabutin and fluoroquinolones in tuberculosis. He is the academic co-ordinator of the EU PreDiCT-TB consortium and recently returned from a two year secondment with the Malawi-Liverpool-Wellcome Clinical Research Programme. Read more about his work in the CIDG ' Meet the Editor' article.
Sarah Donegan (also Statistical Editor)
Research Assistant, Centre for Health Statistics and Health Evaluation, University of Liverpool; and Statistician, Effective Health Care Research Programme Consortium, Liverpool School of Tropical Medicine. Dr. Donegan is currently doing research on indirect comparisons; investigating the impact of cluster randomized trials on quantitative synthesis; teaching statistics in health modules; providing statistical support to review authors; and preparing Cochrane Reviews.
Consultant Paediatrician, Luton and Dunstable University Hospital NHS Foundation Trust, Luton, UK. Dr Eisenhut has published papers on a broad range of subjects, including tuberculosis, malaria, HIV, respiratory syncytial virus bronchiolitis, the pathophysiology of inflammation, sepsis and meningitis and amongst several systematic reviews also two Cochrane Reviews. He is Associate Editor for Cochrane Clinical Answers. He has been the paediatric representative within the National Institute of Health and Care Excellence guideline development group of the United Kingdom updating the guideline on tuberculosis.
Emmanuel is a senior lecturer in the department of Internal Medicine at the University of Calabar, and honorary Consultant Nephrologist at the University of Calabar Teaching Hospital (UCTH). His current position is Senior Research Associate with Cochrane Nigeria, where he co-ordinates training as part of Cochrane Trainers Network and oversees the Branch's mentoring programme. He is also a member of Guideline International Network’s Low and Middle Income Countries working group. He is an experienced Cochrane author across four different groups, and is also an editor with the Cochrane Renal Group. He has experience in clinical audits, priority setting and systematic reviews. Read about his work in the 'Meet the Editor' article.
Clinician and epidemiologist based at Stellenbosch University in South Africa. Dr Eshun-Wilson has experience working with people living with HIV in low and middle income countries in both public health and clinical research settings. She completed a Masters in Epidemiology in 2009 and has worked coordinating primary HIV research projects in East Africa and as a family medicine doctor subsequent to this. She joined the CIDG team in 2016 and works primarily on conducting and appraising Cochrane reviews in the HIV field.
Dr Nathan Ford has worked with the Treatment and Care Unit of the HIV/AIDS Department of the World Health Organization (WHO) since August 2012. Prior to joining WHO he worked with Médecins Sans Frontières (MSF) in a variety of humanitarian contexts. He holds a degree in Microbiology and Virology a Masters in Public Health and Epidemiology and a PhD in Clinical Epidemiology. Areas of concern include evidence-based humanitarian action, and improving quality and access to medical care in resource-limited settings.
Paul Garner, Co-ordinating Editor
Clinical Sciences Group, Liverpool School of Tropical Medicine, Liverpool, UK. Specialist in Research Synthesis. For the last 20 years, Prof Garner has been instrumental in bringing research synthesis to tropical diseases, mainly through CIDG. Currently he is the Director of the Effective Health Care Research Consortium, which is committed to preparing and updating systematic reviews relevant to low- and middle-income countries, and using this research to promote evidence-based health policy and practice.
Hellen Gelband (also Feedback Editor)
Center for Disease Dynamics, Economics & Policy, Washington DC, USA. Hellen Gelband focuses on health policy issues in the United States and internationally. During her career, she has used the evaluation of medical evidence to inform a wide range of both American and global health policies in infectious and non-communicable diseases. Her work at CDDEP explores the growing resistance to antibiotic and anti-malarial drugs, as well as access to and cost of such pharmaceuticals. She coordinates the Global Antibiotic Resistance Partnership, with centers in India, Kenya, Mozambique, Nepal, South Africa, Tanzania, Uganda, and Vietnam to foster evidence-based, feasible policies designed to maintain the effectiveness of and ensure equitable access to effective antibiotics. Other work involves developing cancer policy in low- and middle-income countries. Read more about her work in this CIDG 'Meet the Editor' article and The Lancet article 'Hellen Gelband: botanist turned policy guru in public health'.
Dr. Patricia Graves is a specialist in epidemiology of malaria, filariasis and other vector-borne diseases, with extensive experience in applied research and consulting in the Pacific, Africa and Asia. From 2007 to 2011, she worked as epidemiologist for The Carter Center, Atlanta GA USA, conducting program implementation as well as monitoring and evaluation of integrated control programs for malaria, filariasis and other neglected tropical diseases in Ethiopia and Nigeria. She has been an advisor to the Pacific Regional Filariasis Elimination program since 2000 especially on survey design and evalutation of control programs.
Dr. Graves has been a successful short-term consultant for the World Bank, WHO, AusAID and USAID for support to and evaluation of malaria and filariasis control programmes in Eritrea, Ethiopia, Tanzania, Viet Nam, India, Sri Lanka, Papua New Guinea, Fiji, Vanuatu and Solomon Islands. She also has long-term project management and applied research experience in Papua New Guinea, Solomon Islands, Vanuatu, The Gambia, Ethiopia and Nigeria.
Jimee Hwang is a medical epidemiologist with the Malaria Branch at the Centers for Disease Control and Prevention (CDC) currently seconded to the Malaria Elimination Initiative at the Global Health Group (GHG) at the University of California, San Francisco (UCSF). In her current position, she is the CDC team lead for the President's Malaria Initiative in the Greater Mekong Sub-region and Ethiopia. She trained in the Epidemic Intelligence Service in the Malaria Branch at CDC. She obtained her AB from Dartmouth College, M.D. from Albert Einstein College of Medicine, MPH from University of California, Berkeley, DTM&H from the London School of Hygiene and Tropical Medicine and completed her internal medicine residency at UCSF. Read more about her work in this CIDG 'Meet the Editor' article.
Tamara Kredo is a senior specialist scientist at the South African Medical Research Council and the Deputy Director of the South African Cochrane Centre. She is a medical doctor and specialist in Clinical Pharmacology with a particular interest in evidence-informed healthcare, rational medicine use, and clinical practice guideline development and implementation in lower and middle-income settings. Her current work aims to expand capacity development initiatives for evidence-synthesis in the African region.
Assistant Professor at McMaster University, Canada; Research Methodologist at St Joseph’s Healthcare Hamilton, Canada; Associate staff at the South African Cochrane Centre and Researcher at the Centre for Development of Best Practices in Health, Cameroon. Lawrence joined Cochrane in 2008 via the Reviews for Africa Programme and has since then completed several Cochrane reviews (mainly HIV reviews). His research interests include HIV, mother and child health, health system strengthening and capacity building. Read more about his work in this CIDG 'Meet the Editor' article.
Epidemiologist at the Medical Research Council Unit, The Gambia and Lecturer in the Department of Paediatrics, University of The Gambia. Since, joining Cochrane, Joseph has authored reviews around infectious diseases affecting children in developing countries. His area of interest includes malaria (transmission and elimination), health systems and translational research. Read more about his work in this CIDG 'Meet the Editor' article.
Consultant and Head of Infectious Diseases at Rambam Health Care Campus and Associate Professor at The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. Main clinical and research interests focus on bacterial infections, immune compromised patients, hospital epidemiology and decision support. Dr. Paul has performed a large number of systematic reviews in these fields. Read more about her work in this CIDG 'Meet the Editor' article.
Salvatore Pablo Lucia Professor and Vice Chair, Department of Epidemiology and Biostatistics, and Head, Division of Infectious Disease Epidemiology, University of California, San Francisco. Dr. Rutherford has spent the last 18 years as Coordinating Editor of the Cochrane HIV/AIDS Group prior to its merger with CIDG. He serves as a consultant to the World Health Organization for systematic reviews of antiretroviral treatment and prevention interventions. His reviews focus on the prevention and treatment of HIV.
Clinician, trained in Merseyside, with an interest in tropical and infectious diseases. Currently working with CIDG on systematic reviews in tuberculosis (TB) topics, including the use of corticosteriods with TB meningitis and pleural TB, treatment duration in forms of extrapulmonary TB, and surgery in the treatment of multidrug-resistant TB.
Karen is a public health physician and methodologist. Her main research interest is evidence-based tuberculosis diagnostics. She is an author on several Cochrane diagnostic accuracy reviews of tuberculosis tests, Xpert MTB/RIF assay, MTBDRsl assay, and urine lipoarabinomannan assay. In addition, she has published non-Cochrane systematic reviews on the diagnostic accuracy of tuberculosis tests, including fluorescence microscopy and commercial serological tests. Karen is also an Editor with the Cochrane Diagnostic Test Accuracy Editorial Team. She is a member of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group. Karen has contributed to several recent World Health Organization policies on tuberculosis. She lives in Portland, Oregon, USA. Read more about her work in the CIDG 'Meet the Editor' article.
Yemisi Takwoingi is a medical statistician in the Biostatistics, Evidence Synthesis and Test Evaluation Group based at the School of Health and Population Sciences, University of Birmingham. She is an NIHR Fellow with an interest in methodology for systematic reviews of diagnostic test accuracy (DTA) studies, and the design and conduct of primary studies of medical tests. She also has an interest in methods for keeping reviews up-to-date. She is co-convenor of the Cochrane Screening and Diagnostic Test Methods Group and a member of the Editorial Team for Cochrane DTA reviews. Read more about her work in the CIDG 'Meet the Editor' article.
Olalekan is a physician and systematic reviewer. Dr. Olalekan has worked across a wide range of health technology assessments with a focus on meta-analytical research, HIV/AIDS, other infectious diseases, and socioeconomic determinants in health. He is an experienced Cochrane author. His research area aims to conduct high quality systematic reviews, and to investigate aspects of clinical trial and systematic review methodology.
Charles Shey Wiysonge
Charles Shey Wiysonge is the Director of Cochrane South Africa, the South African Cochrane Centre, at the South African Medical Research Council. He is also Professor in the Department of Global Health at the Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. He joined Cochrane in 2001 as the pioneer Aubrey Sheiham scholar and is an author with several Cochrane Review Groups. Main research interests include vaccines and immunization, knowledge translation, and implementation science. Read more about his work in this CIDG 'Meet the Editor' article.
Julia Critchley is a Professor of Epidemiology in the Population Health Research Institute at St George’s, University of London. She has broad interests in cardiovascular and diabetes epidemiology, as well as in systematic review methods. She has also been developing a research programme focused on common chronic and infectious diseases such as tuberculosis (TB) and diabetes (DM). She recently commenced a new EC FP7 funded consortium; http://tandem-fp7.eu/ and has obtained funding from the Qatari National Research Programme to model the impact of rising DM prevalence on attaining the MDGs for TB and the population effects of treatment and preventative interventions.http://www.sgul.ac.uk/research-profiles-a-z/julia-critchley
Martin is Professor of Paediatrics and Child Health at the College of Medical Sciences, University of Calabar, with special interest in malaria and tropical infections. He leads the clinical trial and evidence-based health care programme of the Calabar Institute of Tropical Diseases Research and Prevention which hosts the Nigerian Branch of the South African Cochrane Centre. He currently chairs the Scientific Board of the newly established Cross River Health and Demographic Surveillance System (CRHDSS) which is a component of the Nigerian Evidence-based Health Systems Initiative (NEHSI), a joint development program of the Federal Government of Nigeria and the Canadian Government.
Scientist, UNICEF/UNDP/World Bank/WHO Special Program on Research & Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland
Thambu David Sudarsanam
Thambu David Sudarsanam is a Physician and Clinical Epidemiology teacher at the Christian Medical College, Vellore and a member of the South Asian Cochrane Center. His interests include infectious disease epidemiology, outbreak management, stroke and health economics. He currently teaches medicine, clinical epidemiology and cochrane methods at his college and in various parts of India.
Deirdre Walshe (Deirdre.Walshe@lstmed.ac.uk)
Information Retrieval Specialist
Vittoria Lutje (Vittoria.Lutje @lstmed.ac.uk)
Information Retrieval Specialist - HIV
Joy Oliver (Joy.Oliver@mrc.ac.za)
Martha Richardson (firstname.lastname@example.org)
Philomena Hinds (Philomena.Hinds@lstmed.ac.uk)
Christianne Esparza (Christianne.Esparza@lstmed.ac.uk)
Each CIDG Cochrane Reviews is refereed by at least two external referees. We are indebted to their contribution. The full list of referees is available in the CIDG module document in the Cochrane Library.